Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Child's Nervous System
Erschienen in: Child's Nervous System 10/2023

03.07.2023 | Review

Technical evolution of pediatric neurosurgery: moyamoya disease

verfasst von: Joo Whan Kim, Toshiaki Hayashi, Seung-Ki Kim, Reizo Shirane

Erschienen in: Child's Nervous System | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Moyamoya disease (MMD) is a rare steno-occlusive disease of the bilateral internal carotid arteries that predominantly occurs in East Asia. Since the first description of the MMD by Suzuki and Takaku in 1969, significant advances have been made in both basic and clinical understanding of the disease. The incidence and prevalence of pediatric MMD have increased, potentially due to improved detection rates. The advancement of neuroimaging techniques has enabled MRI-based diagnostics and detailed visualization of the vessel wall. Various methods of surgical treatments are successful in pediatric MMD patients, and recent studies emphasize the importance of reducing postoperative complications since the goal of MMD surgery is to prevent future cerebral infarction and hemorrhage. Long-term outcomes following appropriate surgical treatment in pediatric MMD patients have shown promising results, including favorable outcomes in very young patients. Further studies with a large patient cohort are needed to establish individualized risk group stratification for determining the optimal timing of surgical treatment and to conduct multidisciplinary outcome assessments.
Literatur
1.
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRef
2.
3.
Tominaga T, Suzuki N, Miyamoto S, Koizumi A, Kuroda S, Takahashi JC, Fujimura M, Houkin K (2018) Recommendations for the management of moyamoya disease: a statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) [2nd Edition]. Surgery for Cerebral Stroke 46:1–24CrossRef
4.
Wintermark M, Hills NK, DeVeber GA, Barkovich AJ, Bernard TJ, Friedman NR, Mackay MT, Kirton A, Zhu G, Leiva-Salinas C, Hou Q, Fullerton HJ (2017) Clinical and imaging characteristics of arteriopathy subtypes in children with arterial ischemic stroke: results of the VIPS study. AJNR Am J Neuroradiol 38:2172–2179PubMedPubMedCentralCrossRef
5.
Ferriero DM, Fullerton HJ, Bernard TJ, Billinghurst L, Daniels SR, DeBaun MR, deVeber G, Ichord RN, Jordan LC, Massicotte P, Meldau J, Roach ES, Smith ER (2019) Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke 50:e51–e96PubMedCrossRef
6.
Ha EJ, Kim KH, Wang KC, Phi JH, Lee JY, Choi JW, Cho BK, Yang J, Byun YH, Kim SK (2019) Long-term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis. Stroke 50:3177–3183PubMedCrossRef
7.
Kuroda S, Houkin K, Ishikawa T, Nakayama N, Ikeda J, Ishii N, Kamiyama H, Iwasaki Y (2004) Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst 20:302–308PubMedCrossRef
8.
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100:142–149PubMed
9.
Ravindran K, Wellons JC, Dewan MC (2019) Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis. Journal of Neurosurgery: Pediatrics PED 24:663–672
10.
Macyszyn L, Attiah M, Ma TS, Ali Z, Faught R, Hossain A, Man K, Patel H, Sobota R, Zager EL, Stein SC (2017) Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study. J Neurosurg 126:1523–1529PubMedCrossRef
11.
Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y (1998) Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 18:321–325PubMedCrossRef
12.
Ishikawa T, Houkin K, Kamiyama H, Abe H (1997) Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 28:1170–1173PubMedCrossRef
13.
Miyamoto S, Akiyama Y, Nagata I, Karasawa J, Nozaki K, Hashimoto N, Kikuchi H (1998) Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus 5:e5PubMedCrossRef
14.
Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056–1066PubMedCrossRef
15.
Hayashi T, Shirane R, Fujimura M, Tominaga T (2010) Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6:73–81PubMedCrossRef
16.
Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54:840–844
17.
Kimiwada T, Hayashi T, Shirane R, Tominaga T (2018) Posterior cerebral artery stenosis and posterior circulation revascularization surgery in pediatric patients with moyamoya disease. J Neurosurg Pediatr 21:632–638PubMedCrossRef
18.
Lee JY, Kim SK, Cheon JE, Choi JW, Phi JH, Kim IO, Cho BK, Wang KC (2013) Posterior cerebral artery involvement in moyamoya disease: initial infarction and angle between PCA and basilar artery. Childs Nerv Syst 29:2263–2269PubMedCrossRef
19.
Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S (2022) 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo) 62:165–170PubMedCrossRef
20.
Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237PubMedCrossRef
21.
Funaki T, Takahashi JC, Takagi Y, Kikuchi T, Yoshida K, Mitsuhara T, Kataoka H, Okada T, Fushimi Y, Miyamoto S (2015) Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications. J Neurosurg 122:400–407PubMedCrossRef
22.
Gatti JR, Torriente AG, Sun LR (2021) Clinical presentation and stroke incidence differ by moyamoya etiology. J Child Neurol 36:272–280PubMedCrossRef
23.
Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42–47PubMedCrossRef
24.
Ahn IM, Park D-H, Hann HJ, Kim KH, Kim HJ, Ahn HS (2014) Incidence, prevalence, and survival of moyamoya disease in Korea. Stroke 45:1090–1095PubMedCrossRef
25.
Lee SU, Kim T, Kwon OK, Bang JS, Ban SP, Byoun HS, Oh CW (2020) Trends in the incidence and treatment of cerebrovascular diseases in Korea: part II. Cerebral infarction, cerebral arterial stenosis, and moyamoya disease. J Korean Neurosurg Soc 63:69–79PubMedCrossRef
26.
Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF (2014) Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study. Stroke 45:1258–1263PubMedCrossRef
27.
28.
Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T (2014) Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke 16:65–72PubMedPubMedCentralCrossRef
29.
Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A (2022) Moyamoya disease: diagnosis and interventions. Lancet Neurol 21:747–758PubMedCrossRef
30.
Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, Jeon P, Kim JS, Hong SC, Bang OY (2014) High-resolution magnetic resonance wall imaging findings of moyamoya disease. Stroke 45:2457–2460PubMedCrossRef
31.
Roder C, Hauser TK, Ernemann U, Tatagiba M, Khan N, Bender B (2019) Arterial wall contrast enhancement in progressive moyamoya disease. J Neurosurg 132:1845–1853PubMedCrossRef
32.
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC (2010) Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68:92–101PubMedCrossRef
33.
Hayashi T, Kimiwada T, Karibe H, Shirane R, Sasaki T, Metoki H, Tominaga T (2021) Preoperative risks of cerebral infarction in pediatric moyamoya disease. Stroke 52:2302–2310PubMedCrossRef
34.
Kawaguchi T, Fujita S, Hosoda K, Shose Y, Hamano S, Iwakura M, Tamaki N (1996) Multiple burr-hole operation for adult moyamoya disease. J Neurosurg 84:468–476PubMedCrossRef
35.
Baba T, Houkin K, Kuroda S (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900–904PubMedCrossRef
36.
Zach V, Bezov D, Lipton RB, Ashina S (2010) Headache associated with moyamoya disease: a case story and literature review. J Headache Pain 11:79–82PubMedCrossRef
37.
Lee JY, Choi YH, Cheon JE, Paeng JC, Ryu HW, Kim KJ, Phi JH, Wang KC, Cho BK, Chae JH, Kim SK (2014) Delayed posterior circulation insufficiency in pediatric moyamoya disease. J Neurol 261:2305–2313PubMedCrossRef
38.
Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK (2005) Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg 103:439–442PubMed
39.
Ma Y, Zhao M, Zhang Q, Liu X, Zhang D, Wang S, Zhang Y, Li M, Zhao J (2018) Risk factors for epilepsy recurrence after revascularization in pediatric patients with moyamoya disease. J Stroke Cerebrovasc Dis 27:740–746PubMedCrossRef
40.
Mori N, Mugikura S, Higano S, Kaneta T, Fujimura M, Umetsu A, Murata T, Takahashi S (2009) The leptomeningeal “ivy sign” on fluid-attenuated inversion recovery MR imaging in moyamoya disease: a sign of decreased cerebral vascular reserve? AJNR Am J Neuroradiol 30:930–935PubMedPubMedCentralCrossRef
41.
Reis CV, Safavi-Abbasi S, Zabramski JM, Gusmão SN, Spetzler RF, Preul MC (2006) The history of neurosurgical procedures for moyamoya disease. Neurosurg Focus 20:E7PubMedCrossRef
42.
Takahashi A, Kamiyama H, Houkin K, Abe H (1995) Surgical treatment of childhood moyamoya disease–comparison of reconstructive surgery centered on the frontal region and the parietal region. Neurol Med Chir (Tokyo) 35:231–237PubMedCrossRef
43.
Kuroda S, Houkin K (2012) Bypass surgery for moyamoya disease: concept and essence of sugical techniques. Neurol Med Chir (Tokyo) 52:287–294PubMedCrossRef
44.
Matsushima T, Inoue T, Katsuta T, Natori Y, Suzuki S, Ikezaki K, Fukui M (1998) An indirect revascularization method in the surgical treatment of moyamoya disease–various kinds of indirect procedures and a multiple combined indirect procedure. Neurol Med Chir (Tokyo) 38(Suppl):297–302PubMedCrossRef
45.
Sato H, Sato N, Tamaki N, Matsumoto S (1990) Chronic low-perfusion state in children with moyamoya disease following revascularization. Childs Nerv Syst 6:166–171PubMedCrossRef
46.
Shimizu T, Aihara M, Yamaguchi R, Sato K, Aishima K, Yoshimoto Y (2020) Large craniotomy increases the risk of minor perioperative complications in revascularization surgery for moyamoya disease. World Neurosurg 141:e498–e507PubMedCrossRef
47.
Choi JW, Chong S, Phi JH, Lee JY, Kim HS, Chae JH, Lee J, Kim SK (2020) Postoperative symptomatic cerebral infarction in pediatric moyamoya disease: risk factors and clinical outcome. World Neurosurg 136:e158–e164PubMedCrossRef
48.
Shimizu T, Aihara M, Yamaguchi R, Aishima K, Shintoku R, Tosaka M, Yoshimoto Y (2023) Impact of craniotomy area on improvement of cerebral blood flow in combined revascularization surgery for moyamoya disease. J Stroke Cerebrovasc Dis 32:107110PubMedCrossRef
49.
Montaser A, Driscoll J, Smith H, Karsten MB, Day E, Mounlavongsy T, Orbach DB, Smith ER (2021) Long-term clinical and radiographic outcomes after pial pericranial dural revascularization: a hybrid surgical technique for treatment of anterior cerebral territory ischemia in pediatric moyamoya disease. J Neurosurg Pediatr 1–9
50.
Kim JW, Phi JH, Lee JY, Koh EJ, Kim KH, Kim HS, Kim SK (2023) Comparison of bifrontal craniotomy and multiple burr hole encephalogaleoperiosteal-synangiosis for pediatric moyamoya disease: an experience of 346 patients. Neurosurgery
51.
Adelson PD, Scott RM (1995) Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg 23:26–33PubMedCrossRef
52.
Riordan CP, Storey A, Cote DJ, Smith ER, Scott RM (2019) Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis. J Neurosurg Pediatr 1–7
53.
Yamamoto S, Yamamoto S, Akai T, Sasahara M, Kuroda S (2022) Differentiation of fibroblasts into myofibroblasts in the arachnoid membrane of moyamoya disease. Stroke 53:3465–3473PubMedCrossRef
54.
Abhinav K, Lee AG, Pendharkar AV, Bigder M, Bet A, Rosenberg-Hasson Y, Cheng MY, Steinberg GK (2023) Comprehensive profiling of secreted factors in the cerebrospinal fluid of moyamoya disease patients. Transl Stroke Res
55.
Byun YH, Phi JH, Lee JY, Ha EJ, Kim KH, Yang J, Kim HS, Ryu SK, Choi JW, Cho BK, Kim SK (2019) Preservation of the arachnoid membrane during encephaloduroarteriosynangiosis reduces postoperative complications without undermining the surgical outcome in pediatric moyamoya disease. World Neurosurg 130:e406–e416PubMedCrossRef
56.
Endo M, Kawano N, Miyaska Y, Yada K (1989) Cranial burr hole for revascularization in moyamoya disease. J Neurosurg 71:180–185PubMedCrossRef
57.
Kawamoto H, Kiya K, Mizoue T, Ohbayashi N (2000) A modified burr-hole method “galeoduroencephalosynangiosis” in a young child with moyamoya disease. A preliminary report and surgical technique. Pediatr Neurosurg 32:272–275PubMedCrossRef
58.
Dusick JR, Gonzalez NR, Martin NA (2011) Clinical and angiographic outcomes from indirect revascularization surgery for moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 68:34–43
59.
Hwang JK, Park EK, Kim J, Kang HC, Kim DS, Shim KW (2021) The feasibility of performing multiple burr hole surgery in pediatric moyamoya patients as a response to failed mEDAS. Childs Nerv Syst 37:2233–2238PubMedCrossRef
60.
Yamagishi N, Hashizume K, Matsuzawa N, Marunaka S, Kitaguchi K, Kurehara K, Karasawa J, Tohho H, Okuda T (1991) Anesthetic management of revascularization for moyamoya disease. Masui 40:1132–1137PubMed
61.
Sato K, Shirane R, Yoshimoto T (1997) Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Childs Nerv Syst 13:68–72PubMedCrossRef
62.
Smith ER, McClain CD, Heeney M, Scott RM (2009) Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus 26:E10PubMedCrossRef
63.
Yokosawa M, Hayashi T, Shirane R, Tominaga T (2014) Efficacy of superficial temporal artery-middle cerebral artery double anastomoses in a patient with rapidly progressive moyamoya disease: case report. Neurol Med Chir (Tokyo) 54:836–840PubMedCrossRef
64.
Hayashi T, Shirane R, Tominaga T (2009) Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure: technical case report. Neurosurgery 64: E195–196; discussion E196
65.
Kim HG, Lee SK, Lee JD (2017) Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease. J Neurosurg Pediatr 19:1–7PubMedCrossRef
66.
Fujimura M, Tominaga T (2012) Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52:327–332PubMedCrossRef
67.
Houkin K, Ishikawa T, Yoshimoto T, Abe H (1997) Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99(Suppl 2):S142-145PubMedCrossRef
68.
Kim SH, Choi JU, Yang KH, Kim TG, Kim DS (2005) Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg 103:433–438PubMed
69.
Kamada C, Hirano T, Mikami T, Komatsu K, Suzuki H, Tsushima S, Akiyama Y, Mikuni N (2021) Additional revascularization using multiple burr holes for PCA involvement in moyamoya disease. J Stroke Cerebrovasc Dis 30:105852PubMedCrossRef
70.
Kahle KT, Duran D, Smith ER (2023) Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics. J Neurosurg Pediatr 31:228–237PubMedCrossRef
Metadaten
Titel
Technical evolution of pediatric neurosurgery: moyamoya disease
verfasst von
Joo Whan Kim
Toshiaki Hayashi
Seung-Ki Kim
Reizo Shirane
Publikationsdatum
03.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 10/2023
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-023-06017-9

Weitere Artikel der Ausgabe 10/2023

Child's Nervous System 10/2023 Zur Ausgabe

Review

Neurosurgical management of non-spastic movement disorders

Original Article

Chiari I malformation: management evolution and technical innovation

Review

Cerebrospinal fluid shunt malfunctions: A reflective review

Review

Technical evolution of pediatric neurosurgery: the evolution of intraoperative imaging

Review

Fetal neurosurgery

Original Article

Pineal/germ cell tumors and pineal parenchymal tumors

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise